Glenmark Generics Limited

Glenmark Pharmaceuticals Limited

Nitin Sharad Chandra Pradhan

Sukumar Sinha

Bobba Venkata Siva Kumar

Mangesh Shivram Sawant

Mubeen Ahmed Khan

Narendra Shriram Joshi

Mubeen Ahmad Khan

Sanjay Anantha Kale

Sankar Arjunan

Girish Dixit

Kosampally Srinivas

Maloyesh Mathuresh Biswas

Biju Kumar Gopinathen Pillai

Pravin Bhalchandra Kulkarni

Girish Bansilal Patel

Sukumar Shinha

An amorphous form of aprepitant and a process for its preparation is provided. Also provided are mixtures of polymorph Forms I and II of aprepitant and a process for the preparation thereof.

Amorphous and crystalline forms of aprepitant and processes for the preparation thereof

A process for the preparation of strontium ranelate or a hydrate thereof is provided comprising (a) reacting a tetraester compound of Formula II: wherein R, R, R, and Rare independently a linear or branched C-Calkyl group or a substituted or unsubstituted C-Ccyclic group, in the presence of a lithium base and in a solvent with an inorganic acid salt of strontium. 

Process for the preparation of strontium ranelate

Processes for the purification of lercanidipine hydrochloride are provided which uses a binary system of an alcohol-containing solvent such as methanol and an aliphatic ester-containing solvent such as isopropyl acetate. Processes for the preparation of substantially amorphous lercanidipine hydrochloride are also provided. Also provided is lercanidipine hydrochloride substantially in polymorph form V.

Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof

A substantially pure dextrorotatory isomer of zopiclone or a pharmaceutically acceptable salt thereof and crystalline forms thereof are provided. Also provided is a process for its preparation and pharmaceutical compositions containing same.

Process for the preparation of an optically active 5H-pyrrolo [3,4-B] pyrazine derivative

A process for preparing a crystalline form of linezolid is provided comprising (a) providing a solution comprising linezolid in an organic solvent having a boiling point of less than or equal to about 150&#xb0; C.; (b) adding an anti-solvent having a boiling point greater than or equal to about 50&#xb0; C. to the solution; and (c) recovering the crystalline form of linezolid.

Process for the preparation of a crystalline form of (S)-N [[3-(3-fluoro-4(4-morpholinyl) phenyl]-2-oxo-5-oxazolidinyl] methyl] acetamide

Growing community of inventors

Thane, India

Nitin Sharad Chandra Pradhan